In glioblastoma, miR-203 expression was diminished in CD133+ cancer stem cells (CSCs) relative to non-CSCs, and its overexpression markedly decreased the self-renewal ability of glioblastoma stem cells [49]. This evidence concerns the gene PROM1 and cancer.